 |
| Tim Bird |
Tim Bird, former CEO of M Booth Health, Health Unlimited and Cooney Waters, has joined LifeSci Communications as executive VP, client services.
With more than 30 years of healthcare PR experience, Bird will help LifeSci clients navigate the complex commercial environment and support their products through the clinic and into the hands of prescribers.
Bird looks forward to “helping the LifeSci team champion innovation, shape health policies, and advance new medicines to fill unmet needs and create lasting change in health.”
Most recently, Bird was running Slope Drive Consulting. He exited the M Booth Health chairman post in July 2022.
He also did stints in the healthcare practices of Hill & Knowlton (senior VP) and Burson-Marsteller (managing director).
LifeSci, which is based in New York, has offices in Boston, London, Madrid and Geneva.
To negotiate the demands of media, investors, regulators and the market, communicators to make sure that their narrative they construct is defensible every stop of the way.
In a health landscape crowded with claims, brands earn trust by pairing credible proof with human stories, cultural relevance, and empowerment.
Binaytara, the Bellevue, WA-based nonprofit dedicated to improving access to cancer care and fostering scientific research, has appointed FINN Partners as its global PR firm.
Jeffrey Sturchio is joining Finn Partners’ health policy and impact group as senior advisor to counsel clients on the issues shaping global health and innovation access.
A breakthrough is not successful merely because it works. It succeeds when people and health systems can actually use it.
